SEC Company Response from CYTOKINETICS INC (CYTK) (CIK 0001061983) (CYTK) — Jan 24, 2017
CYTOKINETICS INC (CYTK) (CIK 0001061983)
Date: Jan. 24, 2017 · CIK: 0001061983 · Accession: 0001193125-17-016727
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-215147
Letter
Acceleration Letter
Cytokinetics, Incorporated
280 East Grand Avenue
South San Francisco, CA 94080
January 24, 2017
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Dorrie Yale
RE: Cytokinetics, Incorporated
Registration Statement on Form S-3
File No. 333-215147
Acceleration Request
Requested Date: January 25, 2017
Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on January 25, 2017, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.
Very truly yours,
Cytokinetics, Incorporated
Show Raw Text
CORRESP
1
filename1.htm
Acceleration Letter
Cytokinetics, Incorporated
280 East Grand Avenue
South San Francisco, CA 94080
January 24, 2017
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Dorrie Yale
RE:
Cytokinetics, Incorporated
Registration Statement on Form S-3
File No. 333-215147
Acceleration
Request
Requested Date: January 25, 2017
Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the
Securities Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on
January 25, 2017, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.
Very truly yours,
Cytokinetics, Incorporated
/s/ Sharon A. Barbari
Sharon A. Barbari
Executive Vice
President, Finance, Chief Financial Officer and Secretary
cc:
Michael E. Tenta, Cooley LLP
J. Carlton Fleming, Cooley LLP